0000939767-22-000041.txt : 20220404
0000939767-22-000041.hdr.sgml : 20220404
20220404201106
ACCESSION NUMBER: 0000939767-22-000041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220331
FILED AS OF DATE: 20220404
DATE AS OF CHANGE: 20220404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haley Patrick J.
CENTRAL INDEX KEY: 0001692954
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 22804807
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 1851 HARBOR BAY PARKWAY
CITY: ALAMEDA
STATE: CA
ZIP: 94502
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
4
1
wf-form4_164911744920111.xml
FORM 4
X0306
4
2022-03-31
0
0000939767
EXELIXIS, INC.
EXEL
0001692954
Haley Patrick J.
C/O EXELIXIS, INC.
1851 HARBOR BAY PARKWAY
ALAMEDA
CA
94502
0
1
0
0
EVP, Commercial
Common Stock
2022-03-31
4
M
0
10000
6.21
A
279191
D
Common Stock
2022-03-31
4
S
0
10000
22.43
D
269191
D
Common Stock
2022-04-01
4
M
0
10000
6.21
A
279191
D
Common Stock
2022-04-01
4
S
0
10000
23
D
269191
D
Common Stock
23539
I
By spouse
Common Stock
10648
I
By 401(k)
Option (right to buy)
6.21
2022-03-31
4
M
0
10000
0
D
2016-09-16
2022-09-15
Common Stock
10000.0
50000
D
Option (right to buy)
6.21
2022-04-01
4
M
0
10000
0
D
2016-09-16
2022-09-15
Common Stock
10000.0
40000
D
Includes 175,508 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 1, 2022.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.32 to $22.55. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 30, 2022.
The option, representing the right to purchase a total of 60,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 16, 2019.
/s/ Christopher J. Senner, Attorney in Fact
2022-04-04